November 6, 2014
BIND Therapeutics Announces Agreement with Merck to Develop Targeted Accurin™ Nanomedicines for Oncology

 
November 6, 2014
Molecular Partners has successfully priced its IPO post re-launch and lists its shares on SIX Swiss Exchange

 
September 23, 2014
Molecular Partners launches IPO on SIX Swiss Exchange

 
September 19, 2014
Kobojo Unveils New Persistent Online RPG Zodiac, Global Project Including Developers from Some of the Most Iconic Role-Playing Games in History

 
September 12, 2014
Symetis Receives CE Mark Approval for Transfemoral Transcatheter Aortic Heart Valve System ACURATE neo™, and Launches Product With First Commercial Implantations

 
more...
© Endeavour Vision SA 2006-2014 Terms & Conditions